Private Equity Firm Acquires Majority Interest in LGM Pharma
LGM Pharma, an active pharmaceutical ingredient (API) supplier, has received a majority equity investment from New Harbor Capital, a Chicago, Illinois-based private equity firm.
LGM Pharma is involved in the distribution of cGMP pharmaceutical ingredients. It specializes in providing integrated sourcing options, technical capabilities, and regulatory documentation support for a wide range of APIs.
Source: LGM Pharma